SELLAS Life Sciences Group, Inc. (SLS)
14.12
-0.04
(-0.28%)
USD |
NASDAQ |
Sep 03, 11:20
SELLAS Life Sciences Group Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -3.00M |
| June 30, 2023 | -2.50M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -4.50M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 1.812M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.018M |
| March 31, 2017 | -0.018M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -1.056M |
| December 31, 2015 | 11.41M |
| September 30, 2015 | -0.247M |
| June 30, 2015 | -0.051M |
| March 31, 2015 | -0.518M |
| December 31, 2014 | -0.109M |
| September 30, 2014 | -3.075M |
| June 30, 2014 | -0.312M |
| March 31, 2014 | -2.032M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Savara, Inc. | 32.60M |
| Lite Strategy, Inc. | 2.098M |
| AbbVie, Inc. | -1.197B |
| Marker Therapeutics, Inc. | 0.00 |
| Rezolute, Inc. | 12.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.588M |
| Cash from Financing (Quarterly) | 38.83M |
| Free Cash Flow | -28.42M |
| Free Cash Flow Per Share (Quarterly) | -0.0401 |
| Free Cash Flow to Equity (Quarterly) | -7.454M |
| Free Cash Flow to Firm (Quarterly) | -7.588M |
| Free Cash Flow Yield | -1.29% |